Objective: Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO4). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients’ beliefs about medicines predict intentional non-adherence to phosphate binders. Method: This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines. Results: Eleven (14.5% of 76) patients reported being intentionally non-adherent to phosphate binders. Patients’ beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels. Conclusion: Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.

Keywords:
Adherence, Phosphate binders, Beliefs about medicines
1.
Block GA, Hulbert Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic haemodialysis patients: a national study. Am J Kidney Dis 1998;31:607–617.
2.
Chiu, Y, Teitelbaum I, Misra M, Marie de Leon E, Adzize T, Mehrotra R: Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 2009;4:1089–1096.
3.
Schmid H, Schiff H, Lederer S R: Pharmacotherapy of end-stage renal disease. Expert Opinion Pharmacother 2010;11:597–613.
4.
Sabaté E: Adherence to Long-Term Therapies. Evidence for Action. Geneva, World Health Organisation, 2003.
5.
Cvengros JA, Christensen AJ: Adherence to dialysis treatment of end-stage renal disease; in O’Donohue WT, Levensky ER (eds): Promoting Treatment Adherence. A Practical Handbook for Health Care Providers. Thousand Oaks, Sage, 2006.
6.
Karamanidou C, Clatworthy J, Weinman J, Horne R: A systematic review of the prevalence and determinants of non-adherence to phosphate binding medication in patients with end stage renal disease. BMC Nephrol 2008;9:2.
7.
Tomson CRV: Summary of findings in the 2009 UK Renal Registry Report. The 12th Annual Report, UK Renal Registry, 2009, chapt 1, pp 3–8.
8.
Kara B, Caglar K, Kilic S: Nonadherence with diet and fluid restrictions and perceived social support in patients receiving haemodialysis. J Nurs Scholarsh 2007;39:243–248.
9.
Lindberg P, Lindberg M: Overcoming obstacles for adherence to phosphate binding medication in dialysis patients: a qualitative study. Pharm World Sci 2008;30:571–576.
10.
Cleary DJ, Matzke GR, Alexander AC, Joy MS: Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm 1995;52:1895–1900.
11.
Long JM, Kee CC, Graham MV, Saethang TB, Dames FD: Medication compliance and the older haemodialysis patient. ANNA J 1998;25:43–49.
12.
Schmid H, Hartmann B, Schiff H: Adherence to prescribed oral medication in adult patients undergoing chronic haemodialysis: a critical review of the literature. Eur J Med Res 2009;14:185–190.
13.
Wroe A, Thomas M: Intentional and unintentional nonadherence in patients prescribed HAART treatment regimens. Psychol Health Med 2003;8:453–463.
14.
Clifford S, Barber N, Horne R: Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res 2008;64:41–46.
15.
Horne R, Weinman J: Patient beliefs about prescribed medicines and their role in adherence to treatment in chronic illness. J Psychosom Res 1999;47:555–567.
16.
Horne R: Compliance, adherence and concordance: implications for asthma treatment. Chest 2006;130(suppl):65S–72S.
17.
Schuz B, Marx C, Wurm S, Warner LM, Ziegelmann JP, Schwarzer R, Tesch-Romer C: Medication beliefs predict medication adherence in older adults with multiple illnesses. J Psychosom Res 2011;70:179–187.
18.
Horne R, Sumner S, Jubraj B, Weinman J, Frost S: Haemodialysis patients’ beliefs about treatment: implications for adherence to medication and fluid-diet restrictions. Int J Pharm Pract 2001;9:169–175.
19.
Gibson P, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, Walters EH: Self-management education and regular practitioner review for adults with asthma. Cochrane Review Cochrane Library 2000;4.
20.
O’Connor S M, Jardine A G, Millar K: The prediction of self-care behaviours in end-stage renal disease patients using Leventhal’s Self-Regulatory Model. J Psychosom Res 2008;65:191–200.
21.
Morisky D, Green L, Levine D: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67–74.
22.
Toll BA, McKee SA, Martin DJ, Jatlow P, O’Malley SS: Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine Tob Res 2007;9:597–605.
23.
Horne R, Weinman J, Hankins M: The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1998;14:1–24.
24.
Weisbord SD, Fried LF, Arnold RM, Rotandi AJ, Fine MJ, Levenson DJ, Switzer GE: Development of a symptom assessment instrument for chronic haemodialysis patients: the dialysis symptom index. J Pain Symptom Manage 2004;27:226–240.
25.
Abdel-Kader K, Unruh ML, Weisbord SD: Symptom burden, depression and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol 2009;4:1057–1064.
26.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
27.
Farley J, Hines S, Musk A, Ferrus S, Tepper V: Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, Pharmacy Refill, Provider Assessment, Caregiver Self-Report, and Appointment Keeping. J Acquir Immune Defic Syndr 2003;33:211–218.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.